IPC
TRIB

Independent Portfolio Consultants’s Trinity Biotech TRIB Stock Holding History

Independent Portfolio Consultants’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3
Closed -$5K – 804
2015
Q3 		$5K Buy
3
+2
+200% +$4.83K ﹤0.01% 765
2015
Q2 		$2K Hold
1
– – ﹤0.01% 836
2015
Q1 		$2K Buy
+1
New +$2.77K ﹤0.01% 888

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Independent Portfolio Consultants's TRIB Position: Q4 2015 in Review

Independent Portfolio Consultants sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 3 shares — an estimated $5K sold.

Independent Portfolio Consultants first reported a position in TRIB in Q1 2015 and held it in 3 quarters. The position peaked at $5K in Q3 2015. 81 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

  • Independent Portfolio Consultants reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 3 Trinity Biotech shares in Q4 2015, an estimated $5K.
  • Independent Portfolio Consultants first reported a position in Trinity Biotech in Q1 2015 and held it in 3 quarters.
  • Independent Portfolio Consultants's Trinity Biotech position peaked at $5K in Q3 2015.
  • 81 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on Independent Portfolio Consultants's 13F filing for Q4 2015, filed 12 Jan 2016.